Pfizer recalls Levoxyl (levothyroxine sodium tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
- Products
-
- Levoxyl (levothyroxine sodium tablets
- Company
- Pfizer
- Where it was sold
-
US Nationwide and Puerto Rico
Nationwide
- Units affected
- 15,815 100-count bottles
- About this recall
- Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.